Fennec Pharmaceuticals (FENC) EBIT Growth (3y) (2013 - 2025)
Fennec Pharmaceuticals (FENC) EBIT Growth (3y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 16.96% |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 38.78% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 13.47% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -12.10% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 69.02% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | Fennec Pharmaceuticals | 292.91 Mn | 256.13 Mn | 12.01 Mn | 25.33% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 25.33% |
| Sep 30, 2025 | 71.18% |
| Jun 30, 2025 | 18.30% |
| Mar 31, 2025 | 38.92% |
| Dec 31, 2024 | 39.45% |
| Sep 30, 2024 | -7.62% |
| Jun 30, 2024 | -8.73% |
| Mar 31, 2024 | 68.59% |
| Dec 31, 2023 | 18.40% |
| Sep 30, 2023 | 44.22% |
| Jun 30, 2023 | 1.25% |
| Mar 31, 2023 | -11.18% |
| Dec 31, 2022 | -18.87% |
| Sep 30, 2022 | -61.85% |
| Jun 30, 2022 | -1.34% |
| Mar 31, 2022 | -9.78% |
| Dec 31, 2021 | -10.65% |
| Sep 30, 2021 | -13.58% |
| Jun 30, 2021 | -13.73% |
| Mar 31, 2021 | -40.08% |